Changeflow GovPing Healthcare & Life Sciences Cell-Free Compositions ATP Regeneration, Bioche...
Routine Rule Added Final

Cell-Free Compositions ATP Regeneration, Biocheminsights Inc

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3924471A1 for cell-free compositions for ATP regeneration and uses thereof, filed by Biocheminsights Inc. The named inventors are William ARMIGER and David DODDS. The application covers multiple IPC classifications including C12N 9/00, C12P 19/26, C12P 19/30, C12P 21/00, and is designated across 31 European patent convention states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 53 changes logged to date.

What changed

The European Patent Office published patent application EP3924471A1 titled 'Cell-Free Compositions for ATP Regeneration and Uses Thereof' filed by Biocheminsights Inc. The application names William ARMIGER and David DODDS as inventors and covers cell-free compositions for ATP regeneration across multiple International Patent Classification codes including oxidoreductases (C12N 9/02), lyases (C12N 9/06), nucleic acid processes (C12P 19/26-36), and peptide processes (C12P 21/00). The patent is designated across 31 European patent convention contracting states.

Biocheminsights Inc now holds a published European patent application for ATP regeneration compositions, which may have implications for competitors developing similar cell-free biochemical systems. Third parties should review the application's claims upon publication in the EPO Register to assess potential freedom-to-operate concerns in European markets.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

CELL-FREE COMPOSITIONS FOR ATP REGENERATION AND USES THEREOF

Publication EP3924471A1 Kind: A1 Apr 15, 2026

Applicants

Biocheminsights Inc.

Inventors

ARMIGER, William, DODDS, David

IPC Classifications

C12N 9/02 20060101AFI20221117BHEP C12N 9/06 20060101ALI20221117BHEP C12N 15/64 20060101ALI20221117BHEP C12N 15/88 20060101ALI20221117BHEP C12N 9/00 20060101ALI20221117BHEP C12P 19/26 20060101ALI20221117BHEP C12P 19/30 20060101ALI20221117BHEP C12P 19/34 20060101ALI20221117BHEP C12P 19/36 20060101ALI20221117BHEP C12P 21/00 20060101ALI20221117BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3924471A1

Who this affects

Applies to
Biotechnology companies Pharmaceutical companies Inventors
Industry sector
3254.1 Biotechnology
Activity scope
Patent publication IP protection Biotech innovation
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!